✦ LIBER ✦

Role of metallothionein1h in cisplatin resistance of non-small cell lung cancer cells

✍ Scribed by Xin-fang Hou; Qing-xia Fan; Liu-xing Wang; Shi-xin Lu

Publisher: Chinese Anti-Cancer Association
Year: 2009
Tongue: English
Weight: 322 KB
Volume: 21
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-009-0247-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transglutaminase 2 as a cisplatin resist

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

✍ Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Oxaliplatin induces drug resistance more

Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells

✍ Britta K. Stordal; Mary W. Davey; Ross A. Davey 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 541 KB

Aberrant methylation of TMS1 in small ce

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer

✍ Arvind Virmani; Asha Rathi; Kenji Sugio; Ubaradka G. Sathyanarayana; Shinichi To 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 320 KB 👁 2 views

## Abstract __TMS1__ (target of methylation‐induced silencing) is a CpG island‐associated gene that functions in the regulation of apoptosis and encodes a caspase recruitment domain, a recently described motif found in apoptotic signaling molecules. Recent evidence suggests that silencing of genes

Combination effects of cisplatin, vinore

Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro

✍ Hitoshi Mogi; Yoshinori Hasegawa; Atsushi Watanabe; Fumio Nomura; Hideo Saka; K. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 694 KB

Mitomycin, ifosfamide and cisplatin in n

Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer

✍ David C. Currie; David W. Miles; Jane S. Drake; Robin Rudd; Stephen G. Spiro; He 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 164 KB

Establishment of a human non-small cell

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib

✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m